Comparison between Anlon Healthcare IPO and M&B Engineering IPO.
Anlon Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while M&B Engineering IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anlon Healthcare IPO is up to ₹121.03 Cr whereas the issue size of the M&B Engineering IPO is up to ₹650.00 Cr. The final issue price of Anlon Healthcare IPO is ₹91.00 per share and of M&B Engineering IPO is ₹385.00 per share.
| Anlon Healthcare IPO | M&B Engineering IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹86.00 per share | ₹366.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹385.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹385.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹36.00 per share | |
| Market Lot Size | 164 shares | 38 shares |
| Fresh Issue Size | 1,33,00,000 shares | 71,48,215 shares |
| Fresh Issue Size (Amount) | up to ₹121.03 Cr | up to ₹275.12 Cr |
| OFS Issue Size | 0 shares | 97,40,259 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹374.88 Cr |
| Issue Size Total | 1,33,00,000 shares | 1,68,88,474 shares |
| Issue Size Total (Amount) | up to ₹121.03 Cr | up to ₹650.00 Cr |
Anlon Healthcare IPO opens on Aug 26, 2025, while M&B Engineering IPO opens on Jul 30, 2025. The closing date of Anlon Healthcare IPO and M&B Engineering IPO is Aug 29, 2025, and Aug 01, 2025, respectively.
| Anlon Healthcare IPO | M&B Engineering IPO | |
|---|---|---|
| Anchor Bid Date | Aug 25, 2025 | Jul 29, 2025 |
| Issue Open | Aug 26, 2025 | Jul 30, 2025 |
| Issue Close | Aug 29, 2025 | Aug 01, 2025 |
| Basis Of Allotment (Tentative) | Sep 01, 2025 | Aug 04, 2025 |
| Initiation of Refunds (Tentative) | Sep 02, 2025 | Aug 05, 2025 |
| Credit of Share (Tentative) | Sep 02, 2025 | Aug 05, 2025 |
| Listing date (Tentative) | Sep 03, 2025 | Aug 06, 2025 |
| Anchor Lockin End date 1 | Oct 01, 2025 | Sep 02, 2025 |
| Anchor Lockin End date 2 | Nov 30, 2025 | Nov 01, 2025 |
Anlon Healthcare IPO P/E ratio is 17.67, as compared to M&B Engineering IPO P/E ratio of 24.98.
| Anlon Healthcare IPO | M&B Engineering IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anlon Healthcare Ltd.'s revenue increased by 81% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)M&B Engineering Ltd.'s revenue increased by 23% and profit after tax (PAT) rose by 69% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 70.26 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.68 | 70.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.67 | 24.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹483.68 Cr. | ₹2200.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.45% | 25.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.93% | 24.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.73 | 0.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.15 | ₹15.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 25.51% | 25.14% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anlon Healthcare IPO Retail Individual Investors (RII) are offered 13,30,000 shares while in M&B Engineering IPO retail investors are offered 13,30,000 shares. Qualified Institutional Buyers (QIB) are offered 99,75,000 shares in Anlon Healthcare IPO and 50,49,351 shares in M&B Engineering IPO.
| Anlon Healthcare IPO | M&B Engineering IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 75,74,026 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 99,75,000 shares | 50,49,351 shares |
| NII | 19,95,000 shares | 25,24,675 shares |
| RII | 13,30,000 shares | 16,83,116 shares |
| Employee | 0 shares | 57,306 shares |
| Others | ||
| Total | 1,33,00,000 shares | 1,68,88,474 shares |
Anlon Healthcare IPO subscribed 7.12x in total, whereas M&B Engineering IPO subscribed 38.11x.
| Anlon Healthcare IPO | M&B Engineering IPO | |
|---|---|---|
| QIB (times) | 1.07x | 38.63x |
| NII (times) | 10.61x | 40.22x |
| Big NII (times) | 7.56x | 39.68x |
| Small NII (times) | 16.69x | 41.31x |
| RII (times) | 47.26x | 34.36x |
| Employee (times) | 8.59x | |
| Other (times) | ||
| Total (times) | 7.12x | 38.11x |
